What is a stock summary page? Click here for an overview.
Business Description
HBM Holdings Ltd
NAICS : 541714
SIC : 2834
ISIN : KYG4403H1002
Share Class Description:
HKSE:02142: Ordinary SharesCompare
Compare
Traded in other countries / regions
02142.Hong Kong6XY.GermanyHBMHF.USA IPO Date
2020-12-10Description
HBM Holdings Ltd is a clinical-stage biopharmaceutical company engaged in the discovery and development of differentiated antibody therapeutics in immunology and oncology disease areas. Its products under development are Batoclimab, for the treatment of a wide spectrum of autoimmune diseases; Tanfanercept, for the treatment of moderate-to-severe dry eye disease (DED); HBM4003; HBM9378, to prevent and treat COVID-19, the pandemic respiratory disease caused by the SARS-CoV-2 virus; HBM7008; and others. Its geographical segments are Mainland China, United States, Europe, and others. The majority of the revenue for the firm is generated from the United States.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 2.72 | |||||
| Equity-to-Asset | 0.58 | |||||
| Debt-to-Equity | 0.49 | |||||
| Debt-to-EBITDA | 6.04 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 6.81 | |||||
| Beneish M-Score | -3.76 | |||||
| WACC vs ROIC | ||||||
Growth Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 102.7 | |||||
| 3-Year Book Growth Rate | -17.3 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 67.31 | |||||
| 9-Day RSI | 59.42 | |||||
| 14-Day RSI | 57.39 | |||||
| 3-1 Month Momentum % | 133.24 | |||||
| 6-1 Month Momentum % | 514.73 | |||||
| 12-1 Month Momentum % | 566.39 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.82 | |||||
| Quick Ratio | 2.79 | |||||
| Cash Ratio | 2.4 | |||||
| Days Inventory | 121.61 | |||||
| Days Sales Outstanding | 200.67 | |||||
| Days Payable | 706.88 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | 0.6 | |||||
| Shareholder Yield % | 1.33 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 88.25 | |||||
| Operating Margin % | -5.72 | |||||
| Net Margin % | 7.29 | |||||
| FCF Margin % | 80.18 | |||||
| ROE % | 2.27 | |||||
| ROA % | 1.26 | |||||
| ROIC % | -2.32 | |||||
| 3-Year ROIIC % | 477.8 | |||||
| ROC (Joel Greenblatt) % | 45.75 | |||||
| ROCE % | 4.61 | |||||
| Years of Profitability over Past 10-Year | 2 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 283.1 | |||||
| PE Ratio without NRI | 283.1 | |||||
| Price-to-Owner-Earnings | 28.02 | |||||
| PS Ratio | 21.11 | |||||
| PB Ratio | 6.21 | |||||
| Price-to-Tangible-Book | 6.62 | |||||
| Price-to-Free-Cash-Flow | 24.65 | |||||
| Price-to-Operating-Cash-Flow | 24.51 | |||||
| EV-to-EBIT | 102.9 | |||||
| EV-to-Forward-EBIT | -0.84 | |||||
| EV-to-EBITDA | 73.58 | |||||
| EV-to-Forward-EBITDA | -0.86 | |||||
| EV-to-Revenue | 19.55 | |||||
| EV-to-Forward-Revenue | 1.42 | |||||
| EV-to-FCF | 24.38 | |||||
| Price-to-GF-Value | 5.1 | |||||
| Price-to-Graham-Number | 9.12 | |||||
| Price-to-Net-Current-Asset-Value | 7.33 | |||||
| Price-to-Net-Cash | 10.14 | |||||
| Earnings Yield (Greenblatt) % | 0.97 | |||||
| FCF Yield % | 3.48 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
HBM Holdings Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil HK$) | 297.034 | ||
| EPS (TTM) (HK$) | 0.029 | ||
| Beta | 2.47 | ||
| 3-Year Sharpe Ratio | 0.71 | ||
| 3-Year Sortino Ratio | 1.65 | ||
| Volatility % | 130.73 | ||
| 14-Day RSI | 57.39 | ||
| 14-Day ATR (HK$) | 0.718561 | ||
| 20-Day SMA (HK$) | 7.6455 | ||
| 12-1 Month Momentum % | 566.39 | ||
| 52-Week Range (HK$) | 1.06 - 10 | ||
| Shares Outstanding (Mil) | 834.8 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
HBM Holdings Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
HBM Holdings Ltd Stock Events
| Event | Date | Price (HK$) | ||
|---|---|---|---|---|
| No Event Data | ||||
HBM Holdings Ltd Frequently Asked Questions
What is HBM Holdings Ltd(HKSE:02142)'s stock price today?
The current price of HKSE:02142 is HK$8.21. The 52 week high of HKSE:02142 is HK$10.00 and 52 week low is HK$1.06.
When is next earnings date of HBM Holdings Ltd(HKSE:02142)?
The next earnings date of HBM Holdings Ltd(HKSE:02142) is .
Does HBM Holdings Ltd(HKSE:02142) pay dividends? If so, how much?
HBM Holdings Ltd(HKSE:02142) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers